Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology

Giovanni Gambassi; Kl Lapane; Antonio Sgadari; Pierugo Carbonin; C Gatsonis; La Lipsitz; V Mor; Roberto Bernabei

Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology

Giovanni Gambassi, Kl Lapane, Antonio Sgadari, Pierugo Carbonin, C Gatsonis, La Lipsitz, V Mor, Roberto Bernabei

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

Randomized trials have shown that angiotensin-converting enzyme (ACE) inhibitors reduce mortality and morbidity, and improve symptoms and exercise tolerance in selected patients with congestive heart failure (CHF). There is, however, no evidence on the effectiveness of ACE inhibitors in the typical, very old and frail patients with CHF.

Lingua originale	English
pagine (da-a)	53-60
Numero di pagine	8
Rivista	Archives of Internal Medicine
Volume	160
Stato di pubblicazione	Pubblicato - 2000

Keywords

Activities of Daily Living
Aged
Aged, 80 and over
Angiotensin-Converting Enzyme Inhibitors
Cardiotonic Agents
Confounding Factors (Epidemiology)
Digoxin
Drug Therapy, Combination
Female
Heart Failure
Hospitalization
Humans
Male
Proportional Hazards Models
Retrospective Studies
Risk
Treatment Outcome

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{066dae46a414411296ca2931c346574f,

title = "Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology",

abstract = "Randomized trials have shown that angiotensin-converting enzyme (ACE) inhibitors reduce mortality and morbidity, and improve symptoms and exercise tolerance in selected patients with congestive heart failure (CHF). There is, however, no evidence on the effectiveness of ACE inhibitors in the typical, very old and frail patients with CHF.",

keywords = "Activities of Daily Living, Aged, Aged, 80 and over, Angiotensin-Converting Enzyme Inhibitors, Cardiotonic Agents, Confounding Factors (Epidemiology), Digoxin, Drug Therapy, Combination, Female, Heart Failure, Hospitalization, Humans, Male, Proportional Hazards Models, Retrospective Studies, Risk, Treatment Outcome, Activities of Daily Living, Aged, Aged, 80 and over, Angiotensin-Converting Enzyme Inhibitors, Cardiotonic Agents, Confounding Factors (Epidemiology), Digoxin, Drug Therapy, Combination, Female, Heart Failure, Hospitalization, Humans, Male, Proportional Hazards Models, Retrospective Studies, Risk, Treatment Outcome",

author = "Giovanni Gambassi and Kl Lapane and Antonio Sgadari and Pierugo Carbonin and C Gatsonis and La Lipsitz and V Mor and Roberto Bernabei",

year = "2000",

language = "English",

volume = "160",

pages = "53--60",

journal = "Archives of Internal Medicine",

issn = "0003-9926",

publisher = "Chicago, IL : American Medical Association, [2013]-",

}

Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology. / Gambassi, Giovanni; Lapane, Kl; Sgadari, Antonio et al.
In: Archives of Internal Medicine, Vol. 160, 2000, pag. 53-60.

Risultato della ricerca: Contributo in rivista › Articolo in rivista

TY - JOUR

T1 - Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology

AU - Gambassi, Giovanni

AU - Lapane, Kl

AU - Sgadari, Antonio

AU - Carbonin, Pierugo

AU - Gatsonis, C

AU - Lipsitz, La

AU - Mor, V

AU - Bernabei, Roberto

PY - 2000

Y1 - 2000

N2 - Randomized trials have shown that angiotensin-converting enzyme (ACE) inhibitors reduce mortality and morbidity, and improve symptoms and exercise tolerance in selected patients with congestive heart failure (CHF). There is, however, no evidence on the effectiveness of ACE inhibitors in the typical, very old and frail patients with CHF.

AB - Randomized trials have shown that angiotensin-converting enzyme (ACE) inhibitors reduce mortality and morbidity, and improve symptoms and exercise tolerance in selected patients with congestive heart failure (CHF). There is, however, no evidence on the effectiveness of ACE inhibitors in the typical, very old and frail patients with CHF.

KW - Activities of Daily Living

KW - Aged

KW - Aged, 80 and over

KW - Angiotensin-Converting Enzyme Inhibitors

KW - Cardiotonic Agents

KW - Confounding Factors (Epidemiology)

KW - Digoxin

KW - Drug Therapy, Combination

KW - Female

KW - Heart Failure

KW - Hospitalization

KW - Humans

KW - Male

KW - Proportional Hazards Models

KW - Retrospective Studies

KW - Risk

KW - Treatment Outcome

KW - Activities of Daily Living

KW - Aged

KW - Aged, 80 and over

KW - Angiotensin-Converting Enzyme Inhibitors

KW - Cardiotonic Agents

KW - Confounding Factors (Epidemiology)

KW - Digoxin

KW - Drug Therapy, Combination

KW - Female

KW - Heart Failure

KW - Hospitalization

KW - Humans

KW - Male

KW - Proportional Hazards Models

KW - Retrospective Studies

KW - Risk

KW - Treatment Outcome

UR - http://hdl.handle.net/10807/37450

M3 - Article

SN - 0003-9926

VL - 160

SP - 53

EP - 60

JO - Archives of Internal Medicine

JF - Archives of Internal Medicine

ER -

Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology

Abstract

Keywords

Altri file e collegamenti

Fingerprint

Cita questo